glp-1 drugs market dynamics 2025 Receptor Agonist Size, Trends and Share Report 2026 Glucagon-like Peptide 1 (GLP-1) Analogues
Description
You have sleep patterns
Finally, a retrospective cohort study compared 1775 matched pairs of SGLT2i users and nonusers with SLE and type 2 diabetes from the TriNetX database and found that use of SGLT2i was associated with significantly reduced risk of lupus nephritis, dialysis, kidney transplant, heart failure, and all-cause mortality compared with no SGLT2i use 8 9,10
doi: 10.2147/dddt.s31443
Anjana RM, Pradeepa R, Unnikrishnan R, Tiwaskar M, Aravind SR, Saboo B, Joshi SR, Mohan V
